Peter Diamandis is the Co-founder and General Partner of BOLD Capital Partners. See contact routes.
Peter Diamandis is the Co-founder and General Partner of BOLD Capital Partners, a venture capital firm managing approximately $600 million that he launched in 2015 to invest in early-stage technology companies. His investment thesis targets early-stage ventures in biotechnology, human longevity, and the commercial space industry, leveraging exponential technologies to drive advancement. While specific check sizes and lead/follow behavior are not explicitly detailed in available sources, the firm focuses on early-stage companies within these sectors. Notable portfolio companies and ventures he has co-founded include Human Longevity Inc., Celularity, Vaxxinity, and Fountain Life, which align with his longevity and health-tech focus. Diamandis is also the Founder and Executive Chairman of the XPRIZE Foundation, which has deployed over $600 million in global incentive competitions, and the Executive Founder of Singularity University. He is recognized by Fortune as one of the “World’s 50 Greatest Leaders” and publicly advocates for using incentive competitions and exponential tech to solve major human challenges.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Santa Monica.
Investors like Peter Diamandis · Full investor directory · Investor access · Company funding database